Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy fkansteiner Fri, 10/18/2024 – 15:21 More: Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy Source: fierce
read moreLilly joins OAC campaign against obesity stigma, partnering on gallery of bias-free images for use in media coverage apark Fri, 10/18/2024 – 11:06 More: Lilly joins OAC campaign against obesity stigma, partnering on gallery of bias-free images for use in
read moreEU drug reviewers back Novo Nordisk’s FDA-rejected hemophilia drug, snub PTC’s Translarna again zbecker Fri, 10/18/2024 – 10:56 More: EU drug reviewers back Novo Nordisk’s FDA-rejected hemophilia drug, snub PTC’s Translarna again Source: fierce
read moreBaxter to import 18,000 tons of IV product by year-end as hurricane recovery efforts continue in NC fkansteiner Fri, 10/18/2024 – 10:19 More: Baxter to import 18,000 tons of IV product by year-end as hurricane recovery efforts continue in NC
read moreGilead pulls Trodelvy’s approval in bladder cancer after trial flop, FDA discussions aliu Fri, 10/18/2024 – 10:04 More: Gilead pulls Trodelvy's approval in bladder cancer after trial flop, FDA discussions Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals